US Stock MarketDetailed Quotes

APRE Aprea Therapeutics

Watchlist
  • 3.230
  • +0.150+4.87%
Close Dec 19 16:00 ET
17.55MMarket Cap-1.15P/E (TTM)

Aprea Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
16.30%4.1M
5.35%3.85M
-31.86%3.15M
-58.60%15.47M
38.59%3.67M
-16.13%3.52M
-83.73%3.65M
-42.75%4.62M
-0.20%37.37M
-66.13%2.65M
Selling and administrative expenses
-6.66%1.61M
8.95%1.85M
-42.67%1.93M
-59.81%8.43M
-22.49%1.64M
-44.21%1.72M
-89.13%1.7M
-15.54%3.37M
54.75%20.97M
-37.02%2.12M
-General and administrative expense
-6.66%1.61M
8.95%1.85M
-42.67%1.93M
-59.81%8.43M
-22.49%1.64M
-44.21%1.72M
-89.13%1.7M
-15.54%3.37M
54.75%20.97M
-37.02%2.12M
Research and development costs
34.10%2.85M
16.12%2.56M
27.36%1.6M
-53.50%7.63M
284.96%2.05M
89.93%2.12M
-67.66%2.2M
-69.27%1.26M
-31.36%16.4M
-88.09%531.41K
Other operating expenses
-11.00%-354.62K
-124.91%-561.57K
---380.57K
---583.23K
---14.08K
---319.47K
---249.69K
----
----
----
Operating profit
-16.30%-4.1M
-5.35%-3.85M
31.86%-3.15M
58.60%-15.47M
-38.59%-3.67M
16.13%-3.52M
83.73%-3.65M
42.75%-4.62M
0.20%-37.37M
66.13%-2.65M
Net non-operating interest income expense
8.57%348.74K
13.73%382.37K
10.53%283.4K
172.84%1.22M
27.65%310.29K
112.55%321.22K
540.53%336.22K
12,909.13%256.41K
27,124.94%448.67K
7,208.54%243.08K
Non-operating interest income
8.57%348.74K
13.73%382.37K
10.53%283.4K
172.84%1.22M
27.65%310.29K
112.55%321.22K
540.53%336.22K
--256.41K
27,124.94%448.67K
--243.08K
Other net income (expense)
-1,132.43%-35.49K
-109.76%-5.5K
507.16%56.18K
99.95%-38.93K
-133.99%-78.61K
-111.83%-2.88K
100.07%56.36K
-110.13%-13.8K
-23,962.06%-75.74M
-147.88%-33.6K
Gain on sale of security
-1,132.43%-35.49K
-109.76%-5.5K
507.16%56.18K
-113.83%-38.93K
-133.99%-78.61K
-111.83%-2.88K
-63.53%56.36K
-110.13%-13.8K
-11.30%281.53K
-147.88%-33.6K
Special income (charges)
----
----
----
--0
----
----
----
----
---76.02M
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
--76.02M
--0
Income before tax
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
Income tax
Net income
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
Net income continuous Operations
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
Minority interest income
Net income attributable to the parent company
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
Basic earnings per share
25.58%-0.64
33.33%-0.58
50.00%-0.67
94.19%-3.95
0.00%-0.92
62.93%-0.86
99.00%-0.87
81.52%-1.34
-94.93%-67.99
87.22%-0.92
Diluted earnings per share
25.58%-0.64
33.33%-0.58
50.00%-0.67
94.19%-3.95
0.00%-0.92
62.93%-0.86
99.00%-0.87
81.52%-1.34
-94.93%-67.99
87.22%-0.92
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 16.30%4.1M5.35%3.85M-31.86%3.15M-58.60%15.47M38.59%3.67M-16.13%3.52M-83.73%3.65M-42.75%4.62M-0.20%37.37M-66.13%2.65M
Selling and administrative expenses -6.66%1.61M8.95%1.85M-42.67%1.93M-59.81%8.43M-22.49%1.64M-44.21%1.72M-89.13%1.7M-15.54%3.37M54.75%20.97M-37.02%2.12M
-General and administrative expense -6.66%1.61M8.95%1.85M-42.67%1.93M-59.81%8.43M-22.49%1.64M-44.21%1.72M-89.13%1.7M-15.54%3.37M54.75%20.97M-37.02%2.12M
Research and development costs 34.10%2.85M16.12%2.56M27.36%1.6M-53.50%7.63M284.96%2.05M89.93%2.12M-67.66%2.2M-69.27%1.26M-31.36%16.4M-88.09%531.41K
Other operating expenses -11.00%-354.62K-124.91%-561.57K---380.57K---583.23K---14.08K---319.47K---249.69K------------
Operating profit -16.30%-4.1M-5.35%-3.85M31.86%-3.15M58.60%-15.47M-38.59%-3.67M16.13%-3.52M83.73%-3.65M42.75%-4.62M0.20%-37.37M66.13%-2.65M
Net non-operating interest income expense 8.57%348.74K13.73%382.37K10.53%283.4K172.84%1.22M27.65%310.29K112.55%321.22K540.53%336.22K12,909.13%256.41K27,124.94%448.67K7,208.54%243.08K
Non-operating interest income 8.57%348.74K13.73%382.37K10.53%283.4K172.84%1.22M27.65%310.29K112.55%321.22K540.53%336.22K--256.41K27,124.94%448.67K--243.08K
Other net income (expense) -1,132.43%-35.49K-109.76%-5.5K507.16%56.18K99.95%-38.93K-133.99%-78.61K-111.83%-2.88K100.07%56.36K-110.13%-13.8K-23,962.06%-75.74M-147.88%-33.6K
Gain on sale of security -1,132.43%-35.49K-109.76%-5.5K507.16%56.18K-113.83%-38.93K-133.99%-78.61K-111.83%-2.88K-63.53%56.36K-110.13%-13.8K-11.30%281.53K-147.88%-33.6K
Special income (charges) --------------0-------------------76.02M--0
-Less:Other special charges ----------------------------------76.02M--0
Income before tax -18.08%-3.78M-6.47%-3.47M35.84%-2.81M87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M
Income tax
Net income -18.08%-3.78M-6.47%-3.47M35.84%-2.81M87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M
Net income continuous Operations -18.08%-3.78M-6.47%-3.47M35.84%-2.81M87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M
Minority interest income
Net income attributable to the parent company -18.08%-3.78M-6.47%-3.47M35.84%-2.81M87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -18.08%-3.78M-6.47%-3.47M35.84%-2.81M87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M
Basic earnings per share 25.58%-0.6433.33%-0.5850.00%-0.6794.19%-3.950.00%-0.9262.93%-0.8699.00%-0.8781.52%-1.34-94.93%-67.9987.22%-0.92
Diluted earnings per share 25.58%-0.6433.33%-0.5850.00%-0.6794.19%-3.950.00%-0.9262.93%-0.8699.00%-0.8781.52%-1.34-94.93%-67.9987.22%-0.92
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data